Bicarbonate

Bicarbonate

SCHEMBL1663419

CC1CCC(C(C)C)C(OCC(O)CO)C1.O=C(O)O

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.60
KDM4E B2RXH2 1/20 0.57
APOBEC3A P31941 1/20 0.57
APOBEC3G Q9HC16 1/20 0.57
GAA P10253 1/20 0.56
MAPT P10636 1/20 0.56
ALDH1A1 P00352 4/20 0.55
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
NTSR1 P30989 1/20 0.55
NPSR1 Q6W5P4 1/20 0.55
CYP1A2 P05177 1/20 0.52
CYP2D6 P10635 1/20 0.52
CYP2C9 P11712 1/20 0.52
XBP1 P17861 1/20 0.52
CYP2C19 P33261 1/20 0.52
P2RX4 Q99571 1/20 0.45
EPHX1 P07099 3/20 0.44
CYP19A1 P11511 2/20 0.43
SERPINE1 P05121 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL29009712 0.96 LMNA (0.58) LMNAKDM4EAPOBEC3AAPOBEC3GGAA
SCHEMBL4749641 0.94 LMNA (0.65) LMNAKDM4EAPOBEC3AAPOBEC3GGAA
SCHEMBL10014116 0.94 LMNA (0.65) LMNAKDM4EAPOBEC3AAPOBEC3GGAA
SCHEMBL19809887 0.94 LMNA (0.65) LMNAKDM4EAPOBEC3AAPOBEC3GGAA
SCHEMBL6421580 0.94 LMNA (0.65) LMNAKDM4EAPOBEC3AAPOBEC3GGAA
SCHEMBL1618051 0.94 LMNA (0.65) LMNAKDM4EAPOBEC3AAPOBEC3GGAA
SCHEMBL1617431 0.94 LMNA (0.65) LMNAKDM4EAPOBEC3AAPOBEC3GGAA
SCHEMBL15144383 0.94 LMNA (0.65) LMNAKDM4EAPOBEC3AAPOBEC3GGAA
SCHEMBL110177 0.94 LMNA (0.65) LMNAKDM4EAPOBEC3AAPOBEC3GGAA
SCHEMBL14565715 0.94 LMNA (0.65) LMNAKDM4EAPOBEC3AAPOBEC3GGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240058243-A1 A METHOD FOR FIGHTING MICROORGANISMS USING MENTHOL DERIVATIVES SYMRISE AG (DE) 2024-02-22 US claimed
EP-4259287-A1 A METHOD FOR FIGHTING MICROORGANISMS USING MENTHOL DERIVATIVES Symrise AG (DE) 2023-10-18 EP claimed
EP-3081207-B1 USE OF A LIPOSOME COMPOSITION SYMRISE AG (DE) 2022-09-21 EP claimed
WO-2022122144-A1 A METHOD FOR FIGHTING MICROORGANISMS USING MENTHOL DERIVATIVES SYMRISE AG (DE) 2022-06-16 WO claimed
EP-3687311-A1 AMIDES FOR GENERATING A TRIGEMINAL EFFECT Symrise AG (DE) 2020-08-05 EP claimed
EP-3142499-B1 HOMOVANILLIC ACID ESTERS, IN PARTICULAR FOR ACHIEVING AN IMPRESSION OF HEAT AND/OR SPICINESS SYMRISE AG (DE) 2019-10-30 EP claimed
US-10392371-B2 Compounds useful as modulators of TRPM8 SENOMYX, INC. (US) 2019-08-27 US claimed
WO-2016166038-A1 WHITENING COMPOSITIONS SYMRISE AG (DE) 2016-10-20 WO claimed
EP-3081207-A1 WHITENING COMPOSITIONS Symrise AG (DE) 2016-10-19 EP claimed
EP-4192614-B1 PROCESS FOR THE PREPARATION OF MICROCAPSULES SYMRISE AG (DE) 2026-05-06 EP disclosed
EP-4725476-A2 COMPOSITIONS FOR REDUCING SALTY TASTE AND USES THEREOF Firmenich SA (CH) 2026-04-15 EP disclosed
EP-4096714-B1 COMPOSITIONS FOR REDUCING SALTY TASTE AND USES THEREOF FIRMENICH & CIE (CH) 2026-01-28 EP disclosed
US-20260014103-A1 COMBINATION REMEDY SYMRISE AG (DE) 2026-01-15 US disclosed
US-20250387310-A1 COMPOSITIONS THAT ENHANCE THE COOLING EFFECT FIRMENICH INCORPORATED (US) 2025-12-25 US disclosed
WO-2010149798-A2 USE OF POLYOLS FOR ENHANCING THE COOLING EFFECT OF A COOLING SUBSTANCE AND COOLING MIXTURES HAVING AN ENHANCED COOLING EFFECT SYMRISE AG (DE) 2010-12-29 WO disclosed
US-20090054520-A1 OXALIC ACID DERIVATIVES AND USE THEREOF AS PHYSIOLOGICAL COOLING ACTIVE INGREDIENTS SYMRISE GMBH & CO. KG (DE) 2009-02-26 US disclosed
US-20080175800-A1 USE OF SPECIFIC MENTHYL 3-OXOCARBOXYLIC ACID ESTERS AS PHYSIOLOGICALLY ACTIVE COOLING SUBSTANCES SYMRISE GMBH & CO. KG (DE) 2008-07-24 US disclosed
US-20080096969-A1 N alpha-(Menthanecarbonyl)amino acid amides and use thereof as physiological cooling active ingredients SYMRISE GMBH & CO. KG (DE) 2008-04-24 US disclosed
WO-2007138031-A2 MENTHANE CARBOXYLIC ACID N-(ALKYLTHIOALKYL)AMIDES AND USE THEREOF AS PHYSIOLOGICALLY ACTIVE COOLING ACTIVE INGREDIENTS SYMRISE GMBH & CO. KG (DE) 2007-12-06 WO disclosed
US-20070202188-A1 Use of alkene carboxlic acid n alkylamides as flavouring agents SYMRISE GMBH & CO. KG (DE) 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240058243-A1 A METHOD FOR FIGHTING MICROORGANISMS USING MENTHOL DERIVATIVES MGLL, GCDH, GK LMNA 3420/4885KDM4E 386/4885APOBEC3A 1531/4885
US-10392371-B2 Compounds useful as modulators of TRPM8 TRPM8, TRPM4, TRPM6 LMNA 3784/4885KDM4E 4171/4885APOBEC3A 4843/4885
US-20260014103-A1 COMBINATION REMEDY TAS2R43, TAS2R41, TAS2R60 LMNA 2492/4885KDM4E 3646/4885APOBEC3A 4494/4885
US-20090054520-A1 OXALIC ACID DERIVATIVES AND USE THEREOF AS PHYSIOLOGICAL COOLING ACTIVE INGREDIENTS OTC, OAT, HOGA1 LMNA 3908/4885KDM4E 4647/4885APOBEC3A 3883/4885
US-20250387310-A1 COMPOSITIONS THAT ENHANCE THE COOLING EFFECT TAS2R30, TAS2R1, TAS2R20 LMNA 757/4885KDM4E 284/4885APOBEC3A 3475/4885
US-20070202188-A1 Use of alkene carboxlic acid n alkylamides as flavouring agents TAS2R41, TAS2R1, TAS2R14 LMNA 1115/4885KDM4E 3249/4885APOBEC3A 2296/4885
US-20080096969-A1 N alpha-(Menthanecarbonyl)amino acid amides and use thereof as physiological cooling active ingredients NMBR, RIMKLA, NAAA LMNA 929/4885KDM4E 3484/4885APOBEC3A 4504/4885
US-20080175800-A1 USE OF SPECIFIC MENTHYL 3-OXOCARBOXYLIC ACID ESTERS AS PHYSIOLOGICALLY ACTIVE COOLING SUBSTANCES ECI1, OTC, MDH2 LMNA 1781/4885KDM4E 3503/4885APOBEC3A 1584/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.